These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2887523)

  • 1. Generic drugs in reproductive medicine: is the value anticipated the value obtained?
    Keith LG; Method MW
    Int J Fertil; 1987; 32(4):268-78. PubMed ID: 2887523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical therapeutic categories: a contraindication to generic substitution?
    Colaizzi JL; Lowenthal DT
    Clin Ther; 1986; 8(4):370-9. PubMed ID: 3731208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current perspectives on combination oral contraceptives.
    Smith MA; Youngkin EQ
    Clin Pharm; 1984; 3(5):485-96. PubMed ID: 6386284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Oral contraception: failures and risks].
    Foussard-blanpin O; Paillot-renaud P; Bruneau-bigot A
    Lyon Pharm; 1984 Nov; 35(6):385-93. PubMed ID: 12280590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral contraceptives.
    Shearman RP
    Aust Fam Physician; 1984 Sep; 13(9):685-91. PubMed ID: 6508652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The triphasics: insights for effective clinical use.
    Youngkin EQ; Miller LG
    Nurse Pract; 1987 Feb; 12(2):17-8, 23, 26-8. PubMed ID: 3822267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogens in oral contraceptives: historical perspectives.
    Goldzieher JW
    Johns Hopkins Med J; 1982 May; 150(5):165-9. PubMed ID: 7043034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The adverse effects of hormonal therapy.
    Bush TL
    Cardiol Clin; 1986 Feb; 4(1):145-52. PubMed ID: 3518931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen dose in oral contraceptives: FDA committee examines safety and utility of 50 mcg estrogen OCs.
    Contracept Rep; 1994 Mar; 5(1):10-3. PubMed ID: 12287738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critical assessment of generic substitution for the obstetrician-gynecologist.
    Keith LG; Oleszczuk JJ; Ahranjani M
    Int J Fertil Womens Med; 2001; 46(6):286-95. PubMed ID: 11795687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The generics in transplantation and the rules on their use.
    Masri M
    Exp Clin Transplant; 2003 Jun; 1(1):65-8. PubMed ID: 15859910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The brand name versus generic controversy: Is there a segment of the pharmaceutical industry that produces drugs of higher quality?
    Marsh DA; Hoar ME
    Contemp Pharm Pract; 1982; 5(2):130-5. PubMed ID: 10317245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Present status of oral contraceptives: 1. effectiveness; basis for selection; side effects; metabolic changes.
    Kistner RW
    Drug Ther (NY); 1971 Dec; 1(12):14-29. PubMed ID: 12306285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generic low-molecular-weight heparins: some practical considerations.
    Fareed J; Leong WL; Hoppensteadt DA; Jeske WP; Walenga J; Wahi R; Bick RL
    Semin Thromb Hemost; 2004 Dec; 30(6):703-13. PubMed ID: 15630677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contraception for the perimenopausal patient.
    Upton GV
    Obstet Gynecol Clin North Am; 1987 Mar; 14(1):207-27. PubMed ID: 3306520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC
    Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A physician survey on generic drugs and substitution of critical dose medications.
    Banahan BF; Kolassa EM
    Arch Intern Med; 1997 Oct; 157(18):2080-8. PubMed ID: 9382664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breakthrough bleeding number one problem with OC use.
    Contracept Technol Update; 1991 Dec; 12(12):185-90. PubMed ID: 12285219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.